Cargando…
BSCI-18. Identifying novel drivers of lung-to-brain metastasis through in vivo functional genomics
INTRODUCTION: Brain metastases, the most common tumors of the central nervous system, occur in approximately 20% of primary adult cancers. In particular, 40% of patients with non-small cell lung cancer develop brain metastasis. As systemic therapies for the treatment of non-small cell lung cancer be...
Autores principales: | Aghaei, Nikoo, Lam, Fred C, Kasper, Ekkehard, Venugopal, Chitra, Singh, Sheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351282/ http://dx.doi.org/10.1093/noajnl/vdab071.017 |
Ejemplares similares
-
NGMA-5. An in vivo functional genomics screen to identify novel drivers of lung-to-brain metastasis
por: Aghaei, Nikoo, et al.
Publicado: (2021) -
37. IN VIVO FUNCTIONAL GENOMIC SCREEN TO IDENTIFY NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS
por: Aghaei, Nikoo, et al.
Publicado: (2020) -
BSCI-19. Therapeutic intervention of lung-, breast-, and melanoma-brain metastasis
por: Kieliszek, Agata, et al.
Publicado: (2021) -
39. CHARACTERIZING NOVEL INHIBITORS OF BRAIN METASTASIS-INITIATING CELLS
por: Kieliszek, Agata, et al.
Publicado: (2020) -
BSCI-20. THERAPEUTIC TARGETING OF HLA-G IN BRAIN METASTASES
por: Singh, Sheila, et al.
Publicado: (2019)